A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Elderly Patients With Acute Myeloid Leukemia Undergoing Remission Induction Therapy
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Eltrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 27 Jul 2017 Planned End Date changed from 1 Apr 2017 to 1 Jan 2018.
- 27 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Jan 2018.
- 06 Dec 2016 Interim results (n= 13,data cut off: Sep 2014 and June 2016) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.